Ranbaxy has bagged USFDA approval for Imitrex. DRL already sells Imitrex in US markets since November 24, 2008. Analysts expect Ranbaxy to do sales worth -20 million in Q4-FY '09. Imitrex has annual sales of -1.2 billion globally.
Video Rating: 0 / 5
WSFL News Update 03/08/11 7.59a Migraines
Video Rating: 0 /
No comments:
Post a Comment